Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
摘要:
IRAK4 is a critical upstream kinase in the IL-1R/TLR signaling pathway. Inhibition of IRAK4 is hypothesized to be beneficial in the treatment of autoimmune related disorders. A screening campaign identified a pyrazole class of IRAK4 inhibitors that were determined by X-ray crystallography to exhibit an unusual binding mode. SAR efforts focused on the identification of a potent and selective inhibitor with good aqueous solubility and rodent pharmacokinetics. Pyrazole C-3 piperidines were well tolerated, with N-sulfonyl analogues generally having good rodent oral exposure but poor solubility. N-Alkyl piperidines exhibited excellent solubility and reduced exposure. Pyrazoles possessing NI pyridine and fluorophenyl substituents were among the most active. Piperazine 32 was a potent enzyme inhibitor with good cellular activity. Compound 32 reduced the in vivo production of proinflammatory cytokines and was orally efficacious in a mouse antibody induced arthritis disease model of inflammation.
Vilsmeier reagent-mediated synthesis of 6-[(formyloxy)methyl]-pyrazolopyrimidines via a one-pot multiple tandem reaction
作者:Shi-Han Lu、Po-Lin Liu、Fung Fuh Wong
DOI:10.1039/c5ra07707a
日期:——
les as the starting material was developed for the efficient synthesis of 6-[(formyloxy)methyl]-1H-pyrazolo[3,4-d]pyrimidine. This new multiple tandem reaction, involving the Vilsmeier–Haack reaction, the Morgan–Walls reaction, sequential elimination, substitution, and final hydrolysis, afforded formyloxymethyl pyrazolo[3,4-d]pyrimidine products in good yields.
以5-(2-氯乙酰氨基)吡唑为起始原料,开发了一种新的Vilsmeier试剂介导的一锅反应,用于有效合成6-[((甲酰氧基)甲基] -1 H-吡唑并[3,4- d ]嘧啶。这种新的多级串联反应,包括Vilsmeier-Haack反应,Morgan-Walls反应,顺序消除,取代和最终水解,可提供高收率的甲酰氧基甲基吡唑并[3,4- d ]嘧啶产物。